C

CervoMed
D

CRVO

6.85000
USD
-0.08
(-1.15%)
مغلق
حجم التداول
1,092
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
59,613,625
أصول ذات صلة
A
AGIO
-1.080
(-3.04%)
34.410 USD
A
ARWR
-0.300
(-1.92%)
15.320 USD
B
BHVN
0.051
(0.35%)
14.435 USD
BMRN
BMRN
-0.220
(-0.40%)
55.000 USD
GILD
GILD
-0.020
(-0.02%)
108.000 USD
NVS
NVS
-0.250
(-0.22%)
115.740 USD
REGN
REGN
-3.73
(-0.73%)
509.70 USD
S
SAGE
0.16000
(1.75%)
9.28500 USD
VRTX
VRTX
-7.64
(-1.70%)
440.97 USD
A
ALF
-0.005
(-0.05%)
10.575 USD
المزيد
المقالات

العنوان: CervoMed

القطاع: Healthcare
الصناعة: Biotechnology
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction,the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.